UK-CAB 60: HIV and lung health

Friday 4 November 2016

• Venue
• Register for this meeting
• Hotel Details
• Expenses

Programme

Presentations from this meeting:

Personal perspective as a TB patient
TB services across England
HIV and lung health
– Slide set 1
– Slide set 2
– Slide set 3
Conferences feedback:
– IAS and Research for Prevention
– BHIVA Autumn conference
– HIV Glasgow conference

Background reading

Tuberculosis (TB)

NHS Choices for TB: An introduction to TB covering, symptoms, causes, diagnosis and treatment
http://www.nhs.uk/Conditions/Tuberculosis/Pages/Introduction.aspx

 All you need to know about Tuberculosis, explained in six short web clips by MSF:

Would recommend at least watching these two short videos:

1. How the body reacts to tuberculosis (3mins)
   An estimated one-third of the world’s population is infected with TB. But does that mean 2.3 billion people are sick? Fortunately not, as only a small proportion of them actually become so. To understand why, let’s take a closer look at the bacterium itself.

2. Fighting tuberculosis (2.10mins)
   The weapons used to fight tuberculosis are now completely outdated: the diagnostic tools are slow, complicated and unreliable. The drugs used are 50 years old and an effective vaccine for children and adults is still a long way off. But despite all this, there’s some good news on the horizon.

UK TB Stats and Targets:
Despite many people believing TB has been eradicated in the UK it never went away. In fact, the UK experienced a two decade long rise in cases from the mid-1980s. It is only in the last four years that the UK has begun to match the global trend for falling rates of TB, with affected individuals dropping from a peak of 8,919 cases in 2011 to around 6,000 cases annually today.

New TB report shows continuing decline in cases in England

COPD (chronic obstructive pulmonary disease)

What is COPD? 
This is a general introduction to COPD covering causes, symptoms, diagnosis, treatment, diet etc.

HIV positive people on ART have impaired alveolar immunity
BHIVA presentation by Professor Paul Collini from University of Sheffield on some interesting immunological results that suggest that macrophages in the lungs of HIV positive people may be impaired, even after viral suppression on ART.

Webcast from BHIVA : http://www.bhiva.org/160421PaulCollini.aspx (12mins)

Article in HTB: http://i-base.info/htb/30036

Low CD4 count, smoking and unhealthy alcohol use are risk factors for acute exacerbation of COPD in people with HIV

Smoking cessation (COPD) presentation at BHIVA by Dr Louise Restrick: Helping Smokers Quit Adding value to HIV Care?  This webcast is 28 mins.

 Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.